259 related articles for article (PubMed ID: 26062685)
21. [In vitro differentiation into megakaryocytes and generation of platelets from CD34+ cells of umbilical cord blood].
Li X; Chen FP; Liu J; Wu XH; Jiang TB; Tang XY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):776-81. PubMed ID: 17062951
[TBL] [Abstract][Full Text] [Related]
22. Platelet activation induces cell-surface immunoreactive tissue factor expression, which is modulated differently by antiplatelet drugs.
Camera M; Frigerio M; Toschi V; Brambilla M; Rossi F; Cottell DC; Maderna P; Parolari A; Bonzi R; De Vincenti O; Tremoli E
Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1690-6. PubMed ID: 12855480
[TBL] [Abstract][Full Text] [Related]
23. Tissue factor and atherosclerosis: not only vessel wall-derived TF, but also platelet-associated TF.
Camera M; Brambilla M; Facchinetti L; Canzano P; Spirito R; Rossetti L; Saccu C; Di Minno MN; Tremoli E
Thromb Res; 2012 Mar; 129(3):279-84. PubMed ID: 22178579
[TBL] [Abstract][Full Text] [Related]
24. Characterization of induced pluripotent stem cell-derived megakaryocyte lysates for potential regenerative applications.
Baigger A; Eicke D; Yuzefovych Y; Pogozhykh D; Blasczyk R; Figueiredo C
J Cell Mol Med; 2018 Sep; 22(9):4545-4549. PubMed ID: 29893509
[TBL] [Abstract][Full Text] [Related]
25. The presence and release of tissue factor from human platelets.
Siddiqui FA; Desai H; Amirkhosravi A; Amaya M; Francis JL
Platelets; 2002 Jun; 13(4):247-53. PubMed ID: 12189027
[TBL] [Abstract][Full Text] [Related]
26. Differential expression of neuronal dopamine and serotonin transporters DAT and SERT in megakaryocytes and platelets generated from human MEG-01 megakaryoblasts.
Hohmann S; Schweinfurth N; Lau T; Deuschle M; Lederbogen F; Banaschewski T; Schloss P
Cell Tissue Res; 2011 Nov; 346(2):151-61. PubMed ID: 22006250
[TBL] [Abstract][Full Text] [Related]
27. Monocyte IL-10 produced in response to lipopolysaccharide modulates thrombin generation by inhibiting tissue factor expression and release of active tissue factor-bound microparticles.
Poitevin S; Cochery-Nouvellon E; Dupont A; Nguyen P
Thromb Haemost; 2007 Apr; 97(4):598-607. PubMed ID: 17393023
[TBL] [Abstract][Full Text] [Related]
28. Increased Pro-Thrombotic Platelet Activity Associated with Thrombin/PAR1-Dependent Pathway Disorder in Patients with Secondary Progressive Multiple Sclerosis.
Dziedzic A; Miller E; Bijak M; Przyslo L; Saluk-Bijak J
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33086557
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms Regulating Acquisition of Platelet-Derived Factor V/Va by Megakaryocytes.
Gertz JM; Bouchard BA
J Cell Biochem; 2015 Oct; 116(10):2121-6. PubMed ID: 25800007
[TBL] [Abstract][Full Text] [Related]
30. Human platelets synthesize and express functional tissue factor.
Panes O; Matus V; Sáez CG; Quiroga T; Pereira J; Mezzano D
Blood; 2007 Jun; 109(12):5242-50. PubMed ID: 17347408
[TBL] [Abstract][Full Text] [Related]
31. [TGF-beta and platelet].
Kogawa K; Mogi Y; Morii K; Takimoto R; Niitsu Y
Rinsho Ketsueki; 1994 Apr; 35(4):370-5. PubMed ID: 8028182
[TBL] [Abstract][Full Text] [Related]
32. Angiogenic microvascular endothelial cells release microparticles rich in tissue factor that promotes postischemic collateral vessel formation.
Arderiu G; Peña E; Badimon L
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):348-57. PubMed ID: 25425620
[TBL] [Abstract][Full Text] [Related]
33. Thrombin Maybe Plays an Important Role in MK Differentiation into Platelets.
Yang XL; Ge MK; Mao DK; Lv YT; Sun SY; Yu AP
Biomed Res Int; 2016; 2016():9313269. PubMed ID: 27064425
[TBL] [Abstract][Full Text] [Related]
34. Tissue factor expression in blood cells.
Østerud B
Thromb Res; 2010 Apr; 125 Suppl 1():S31-4. PubMed ID: 20149415
[TBL] [Abstract][Full Text] [Related]
35. Platelet tissue factor pathway inhibitor modulates intravascular coagulation.
Maroney SA; Mast AE
Thromb Res; 2012 May; 129 Suppl 2(Suppl 2):S21-2. PubMed ID: 22425319
[TBL] [Abstract][Full Text] [Related]
36. Plasminogen activator inhibitor-1 mRNA is expressed in platelets and megakaryocytes and the megakaryoblastic cell line CHRF-288.
Konkle BA; Schick PK; He X; Liu RJ; Mazur EM
Arterioscler Thromb; 1993 May; 13(5):669-74. PubMed ID: 8485117
[TBL] [Abstract][Full Text] [Related]
37. Oxidative stress and expression of p22phox are involved in the up-regulation of tissue factor in vascular smooth muscle cells in response to activated platelets.
Görlach A; Brandes RP; Bassus S; Kronemann N; Kirchmaier CM; Busse R; Schini-Kerth VB
FASEB J; 2000 Aug; 14(11):1518-28. PubMed ID: 10928986
[TBL] [Abstract][Full Text] [Related]
38. Human mesenchymal stem cells support megakaryocyte and pro-platelet formation from CD34(+) hematopoietic progenitor cells.
Cheng L; Qasba P; Vanguri P; Thiede MA
J Cell Physiol; 2000 Jul; 184(1):58-69. PubMed ID: 10825234
[TBL] [Abstract][Full Text] [Related]
39. Endocytosis and storage of plasma factor V by human megakaryocytes.
Suehiro Y; Veljkovic DK; Fuller N; Motomura Y; Massé JM; Cramer EM; Hayward CP
Thromb Haemost; 2005 Sep; 94(3):585-92. PubMed ID: 16268476
[TBL] [Abstract][Full Text] [Related]
40. Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease.
Mobarrez F; He S; Bröijersen A; Wiklund B; Antovic A; Antovic J; Egberg N; Jörneskog G; Wallén H
Thromb Haemost; 2011 Aug; 106(2):344-52. PubMed ID: 21614411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
